UiPath stock has tumbled as optimism around its automation software has been overtaken by concern about artificial intelligence.

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for ...

UiPath (NYSE:PATH) declined approximately 6% in today’s session, trading below $12 midday on Thursday. The selloff is puzzling on the surface. UiPath just posted a quarter that beat expectations on ...

Automation software company UiPath (NYSE:PATH) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 13.6% year on year to $481.1 million. Guidance for next quarter’s ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

Enterprise automation budgets are shifting from point tools to platforms. Buyers want governance, reuse, and faster time to value across UI, API and document-heavy work. UiPath PATH is leaning into ...

Best AI Software Products Best Agentic AI Software Products Best Development Software Products Best IT Management Software Products Best Global Software Companies “We’re grateful for the trust our ...

Founded in Romania in 2005, UiPath develops AI software that is able to automate boring activities like extracting data, filling documents, or updating databases. The fast-growing market of Robotic ...